AKT1 and acute lymphoblastic leukemia: The first dataset reported mRNA expression profiles of CD8+ T cells, derived from an unrelated study involving three acute lymphocytic leukemia (ALL) patients—designated as patient M, P, and C, and ex vivo treated with a pan-AKT inhibitor VIII [63].